Índice Bovespa

US Dollar vs BRL

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Blue Water Biotech Inc (BWV)
Blue Water Biotech Inc (BWV) Notícias

BWV

Blue Water Biotech (BWV)

Blue Water Biotech Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:BWV

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
21/12/2023	18:56	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BWV	Blue Water Biotech Inc
19/12/2023	09:00	GlobeNewswire Inc.	Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders	NASDAQ:BWV	Blue Water Biotech Inc
18/12/2023	09:00	GlobeNewswire Inc.	Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™	NASDAQ:BWV	Blue Water Biotech Inc
17/11/2023	19:23	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BWV	Blue Water Biotech Inc
02/11/2023	08:00	GlobeNewswire Inc.	Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company	NASDAQ:BWV	Blue Water Biotech Inc
01/11/2023	08:00	GlobeNewswire Inc.	Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)	NASDAQ:BWV	Blue Water Biotech Inc
30/10/2023	08:00	GlobeNewswire Inc.	Blue Water Biotech Issues Letter to Shareholders	NASDAQ:BWV	Blue Water Biotech Inc
10/10/2023	10:00	GlobeNewswire Inc.	Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO	NASDAQ:BWV	Blue Water Biotech Inc
28/08/2023	17:30	GlobeNewswire Inc.	Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q	NASDAQ:BWV	Blue Water Biotech Inc
15/08/2023	18:22	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:BWV	Blue Water Biotech Inc
10/08/2023	10:00	GlobeNewswire Inc.	Blue Water Biotech and Copay Consultants Collaborate to Build Copay Assistance Programs for Blue Water’s Commercial Products	NASDAQ:BWV	Blue Water Biotech Inc
03/08/2023	14:02	GlobeNewswire Inc.	Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds	NASDAQ:BWV	Blue Water Biotech Inc
01/08/2023	09:00	GlobeNewswire Inc.	Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds	NASDAQ:BWV	Blue Water Biotech Inc
31/07/2023	10:00	GlobeNewswire Inc.	Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians	NASDAQ:BWV	Blue Water Biotech Inc
25/07/2023	10:00	GlobeNewswire Inc.	Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®	NASDAQ:BWV	Blue Water Biotech Inc
17/07/2023	10:00	GlobeNewswire Inc.	Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities	NASDAQ:BWV	Blue Water Biotech Inc
11/07/2023	10:00	GlobeNewswire Inc.	Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support	NASDAQ:BWV	Blue Water Biotech Inc
06/07/2023	18:05	GlobeNewswire Inc.	Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products	NASDAQ:BWV	Blue Water Biotech Inc
06/07/2023	08:30	GlobeNewswire Inc.	Blue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product Portfolio	NASDAQ:BWV	Blue Water Biotech Inc
29/06/2023	11:35	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:BWV	Blue Water Biotech Inc
28/06/2023	09:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BWV	Blue Water Biotech Inc
28/06/2023	08:55	GlobeNewswire Inc.	Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform	NASDAQ:BWV	Blue Water Biotech Inc
21/06/2023	08:30	GlobeNewswire Inc.	Blue Water Biotech Collaborates with IQVIA to Build Medical Sales Representative Team to Market Commercial Product Portfolio	NASDAQ:BWV	Blue Water Biotech Inc
14/06/2023	08:30	GlobeNewswire Inc.	Blue Water Biotech Expands Commercial Portfolio by Acquiring Six FDA-Approved Drugs Across Various Treatment Areas	NASDAQ:BWV	Blue Water Biotech Inc
12/05/2023	19:32	GlobeNewswire Inc.	Blue Water Biotech Reports First Quarter 2023 Financial Results and Recent Business Highlights	NASDAQ:BWV	Blue Water Biotech Inc
10/05/2023	13:15	GlobeNewswire Inc.	Blue Water Biotech to Present Corporate Overview and ENTADFI® Launch Plan at the JMP Securities Life Sciences Conference in New York, NY	NASDAQ:BWV	Blue Water Biotech Inc
05/05/2023	07:08	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:BWV	Blue Water Biotech Inc
28/04/2023	18:17	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:BWV	Blue Water Biotech Inc
26/04/2023	18:23	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:BWV	Blue Water Biotech Inc
26/04/2023	16:44	GlobeNewswire Inc.	Blue Water Biotech Appoints Board-Certified Urologist Jay Newmark, M.D., MBA as Chief Medical Officer	NASDAQ:BWV	Blue Water Biotech Inc

Apresentando as notícias mais relevantes sobre:NASDAQ:BWV

1 2 3 Próxima >>

Revelation Biosciences

SG Issuer Sg Issuer Zc M...

First Trust Exchange Tra...

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições